Aeterna Faces Shareholder Suit Over Growth Hormone Drug

Aeterna Zentaris Inc. was hit with a putative class action in New Jersey federal court on Wednesday claiming that the Canadian pharmaceutical company inflated its stock by misleading the investing public about the prospects for a drug to help diagnose adult growth hormone deficiency.